Abstract

The COVID-19 pandemic has brought into sharp focus the need to harness and leverage our digital infrastructure for remote patient monitoring. As current viral tests and vaccines are slow to emerge, we see a need for more robust disease detection and monitoring of individual and population health, which could be aided by wearable sensors. While the utility of this technology has been used to correlate physiological metrics to daily living and human performance, the translation of such technology toward predicting the incidence of COVID-19 remains a necessity. When used in conjunction with predictive platforms, users of wearable devices could be alerted when changes in their metrics match those associated with COVID-19. Anonymous data localized to regions such as neighborhoods or zip codes could provide public health officials and researchers a valuable tool to track and mitigate the spread of the virus, particularly during a second wave. Identifiable data, for example remote monitoring of cohorts (family, businesses, and facilities) associated with individuals diagnosed with COVID-19, can provide valuable data such as acceleration of transmission and symptom onset. This manuscript describes clinically relevant physiological metrics which can be measured from commercial devices today and highlights their role in tracking the health, stability, and recovery of COVID-19+ individuals and front-line workers. Our goal disseminating from this paper is to initiate a call to action among front-line workers and engineers toward developing digital health platforms for monitoring and managing this pandemic.

Highlights

  • Overview of COVID-19The Coronavirus Disease 2019 (COVID-19), first recognized in December 2019 in Wuhan, China, is the latest respiratory disease pandemic currently plaguing global health

  • COVID-19 has posed significant challenges for the medical and civilian communities analogous to what was experienced in two preceding instances of the SARS-CoV virus outbreak in 2002 and 2003 and the Middle East Respiratory Syndrome (MERS) in 2012 [1, 5, 6]

  • Discussion of current clinical trials utilizing commercially available, off-the-shelf (COTS) wearable devices pertinent sensors to COVID-19 is included to highlight the current work in this domain (Table 3)

Read more

Summary

INTRODUCTION

The Coronavirus Disease 2019 (COVID-19), first recognized in December 2019 in Wuhan, China, is the latest respiratory disease pandemic currently plaguing global health. This becomes more relevant when one considers that the asymptomatic carrier rate is estimated to be between 25 and 50% of the entire United States population [16, 17] With such a large population potentially carrying the virus, digital health technologies that measure physiologic parameters can be leveraged to help identify population clusters to identify an emerging COVID-19 outbreak. Harnessing this information is feasible as ∼16% of the United States population (∼52.8 million people) currently have a smartwatch [18]. Discussion of current clinical trials utilizing commercially available, off-the-shelf (COTS) wearable devices pertinent sensors to COVID-19 is included to highlight the current work in this domain (Table 3)

Cardiovascular Monitoring
Temperature x
Act y
Smart Thermometer
Findings
Respiration Monitoring
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call